Interleukin-mediated metastatic tumor suppression: Pro-inflammatory cytokine IL-1β suppresses the expression of a proto-oncogene ANGPT2 and inhibits metasatic progression via up regulation of its target gene, 26/September/2014, 08.10 am

Interleukin-mediated metastatic tumor suppression: Pro-inflammatory cytokine IL-1β suppresses the expression of a proto-oncogene ANGPT2 and inhibits metasatic progression via up regulation of its target gene, 26/September/2014, 08.10 am

Interleukin-mediated metastatic tumor suppression: Pro-inflammatory cytokine IL-1β suppresses the expression of a proto-oncogene ANGPT2 and inhibits metasatic progression via up regulation of its target gene, 26/September/2014, 08.10 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan,  Interleukin-mediated metastatic tumor suppression:  Pro-inflammatory cytokine IL-1β suppresses the expression of a prot0-oncogene  ANGPT2  and inhibits metasatic progression via up regulation of its target gene, 26/September/2014, 08.10 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Significance: This study suggests that IL-1β, by increasing the expression of its target gene, it may decrease the  expression of oncogene ANGPT2. Thereby, it may function as a tumor suppressor. Thus, pharmacological formulations encompassing IL-1β or its activator” may be used to inhibit tumorigenesis. 

* Research cooperation